期刊文献+

中医药治疗肝纤维化研究进展 被引量:4

Progress of Chinese medicine in treating liver fibrosis
下载PDF
导出
摘要 肝纤维化是各种慢性肝病的共同病理学基础,是发展至肝硬化可逆转的最后阶段。研究表明,西药对肝纤维化的治疗缺乏稳定性;近年来,中医药在诊治和研究肝纤维化方面效果显著,主要体现在对病因病机、临床治疗、实验室研究等方面。本文就中医药治疗肝纤维化的研究进展进行综述。 Liver fibrosis is a variety of common pathological basis of chronic liver disease, which is the last stage of the development to cirrhosis of the liver can be reversed. Research shows that western medicine treatment of liver fibrosis is lack of stability; In recent years, traditional Chinese medicine in the treatment and research of liver fibrosis effect significantly, mainly reflected in the etiology and pathogenesis, clinical treatment, laboratory research, etc. In this paper, the traditional Chinese medicine (TCM) combined chemotherapy in the treatment of non - small cell lung cancer research progress were reviewed.
作者 王保芹
机构地区 安徽中医药大学
出处 《中国民族民间医药》 2015年第13期18-19,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 中医药 肝纤维化 traditional Chinese medicine Liver fibrosis
  • 相关文献

参考文献24

二级参考文献193

共引文献323

同被引文献35

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部